FDA-Drug2018-05-30Class II
Loxapine Capsules, USP 50 mg, Rx Only, 100-count bottles, NDC 0378-7050-01
Mylan Pharmaceuticals Inc.
Hazard
CGMP Deviations
Sold states
Product was distributed throughout the United States, including Puerto Rico.
Affected count
11,650 bottles
Manufactured in
781 Chestnut Ridge Rd, N/A, Morgantown, WV, United States
Products
Loxapine Capsules, USP 50 mg, Rx Only, 100-count bottles, NDC 0378-7050-01
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0825-2018Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief